Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-15
    E.g., 2018-10-15

Archive Search

3 results
12:00 AM, Mar 12, 2012  |  BioCentury | Product Development

Replacing the replacements

including JR-032 , a recombinant iduronate-2 sulfatase to treat MPS II; JR-051 , a recombinant alpha galactosidase
an enzyme replacement therapy but rather is a small molecule that enhances the activity of alpha galactosidase
12:00 AM, Oct 27, 2003  |  BioCentury | Product Development

The pharming field

lymphoma (NHL) Completed Ph I Progress to Ph III; on hold due to financing Recombinant alpha- galactosidase
12:00 AM, Sep 23, 2002  |  BioCentury | Product Development

Bitter rivalry

Disorders. The products treat patients who have an inherited disorder that prevents them from producing alpha-galactosidase